MetaBiom
Microbiome & Chronic Diseases

Evidence Based Medicine
Sign in

Erysipelatoclostridium ⇒ Proteus {10000255}

Record Keys


Organism:
Erysipelatoclostridium
Parent:

Details


Initialisation date:
2020-09-30

Meta Information


Rank:
Species
Domain:
Bacteria
Enzyme:[  ]
Function:[  ]

Notes:


[  ]

References Notes


[  ]

Shared Reference Notes


  • [1.7
    - Maternal exposure to #Fructose > reduces the abundance of Erysipelatoclostridium in the infant gut microbiome.
  • [1.8] [#Alzheimer’s disease
    - #Treatment with Rifamixin > significant reduction in serum neurofilament-light levels >significant increase in fecal phylum Firmicutes microbiota. #Treatment with Rifamixin > reduces Serum pTau181 and GFAP levels and non-significant downward trend in serum cytokine IL-6 and IL-13 levels. Increases in stool Erysipelatoclostridium > correlated significantly with reductions in serum pTau 181 and serum GFAP.